Venture Partner at Catalio Capital Management
View Live Interactive Profile →Catalio Capital Management lists Raju Kucherlapati as a Venture Partner. The firm's profile page gives the current affiliation as Professor of Genetics at Harvard Medical School. His stated honours include election to the National Academy of Medicine (2008), membership of the National Advisory Council for Human Genome Research (1999) and service on the Presidential Commission for the Study of Bioethical Issues from 2009 to 2017. Catalio's page lists him as a co-founder of Abgenix, Millennium Pharmaceuticals, Cell Genesys and KEW, Inc. and names board seats at PureTech Health, Gelesis and AVEO Pharmaceuticals; these were not confirmed as current against issuer filings and are therefore not recorded as board seats.